Lexicon Pharmaceuticals, Inc. (LXRX) is a publicly traded Healthcare sector company. As of May 21, 2026, LXRX trades at $2.21 with a market cap of $950.58M and a P/E ratio of -31.07. LXRX moved +4.23% today. Year to date, LXRX is +93.86%; over the trailing twelve months it is +287.72%. Its 52-week range spans $0.28 to $2.53. Analyst consensus is strong buy with an average price target of $4.03. Rallies surfaces LXRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Lexicon Pharmaceuticals, Inc. (LXRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. LXRX moved +4.23% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.21 |
| Market Cap | $950.58M |
| P/E Ratio | -31.07 |
| EPS | $-0.07 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.53 |
| 52-Week Low | $0.28 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $69.64M |
| Net Income | $-26.09M |
| Gross Margin | 99.50% |
4 analysts cover LXRX: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.03.